Winton Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Buy
+14,800
New +$506K 0.02% 686
2025
Q4
Sell
-65,345
Closed -$2.29M 951
2025
Q3
$2.29M Buy
+65,345
New +$2.27M 0.09% 263
2024
Q2
Sell
-42,369
Closed -$1.64M 602
2024
Q1
$1.64M Buy
+42,369
New +$1.48M 0.12% 148
2023
Q2
Sell
-14,145
Closed -$339K 831
2023
Q1
$339K Buy
+14,145
New +$375K 0.02% 790
2022
Q3
Sell
-40,738
Closed -$722K 968
2022
Q2
$722K Sell
40,738
-15,001
-27% -$252K 0.04% 591
2022
Q1
$1.14M Buy
55,739
+2,924
+6% +$55.2K 0.06% 422
2021
Q4
$987K Buy
52,815
+15,226
+41% +$297K 0.06% 467
2021
Q3
$742K Sell
37,589
-7,238
-16% -$157K 0.04% 660
2021
Q2
$1.06M Sell
44,827
-1,875
-4% -$43.3K 0.06% 497
2021
Q1
$1.11M Sell
46,702
-6,318
-12% -$150K 0.06% 402
2020
Q4
$1.06M Sell
53,020
-84,029
-61% -$1.64M 0.08% 377
2020
Q3
$2.85M Sell
137,049
-39,805
-23% -$718K 0.09% 354
2020
Q2
$3.1M Buy
176,854
+54,473
+45% +$1.07M 0.08% 440
2020
Q1
$2M Sell
122,381
-20,418
-14% -$421K 0.05% 577
2019
Q4
$2.94M Buy
142,799
+114,280
+401% +$1.9M 0.04% 662
2019
Q3
$327K Buy
+28,519
New +$326K ﹤0.01% 1244

Other funds holding COLL

Winton Group's COLL Position: Q2 2026 in Review

Winton Group opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 14,800 shares worth $536K. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Winton Group previously reported a position in COLL as recently as Q3 2025.

Winton Group first reported a position in COLL in Q3 2019 and has held it in 16 quarters since. The position peaked at $3.1M in Q2 2020. 149 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Winton Group held 14,800 shares of Collegium Pharmaceutical worth $536K as of Q2 2026.
  • Collegium Pharmaceutical was a new Winton Group position in Q2 2026.
  • Collegium Pharmaceutical made up 0.02% of Winton Group's portfolio in Q2 2026, its #686 holding.
  • Winton Group first reported a position in Collegium Pharmaceutical in Q3 2019 and has held it in 16 quarters since.
  • Winton Group's Collegium Pharmaceutical position peaked at $3.1M in Q2 2020.
  • 149 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.